Xeltis has announced successful results from its aXess EU phase 3 trial, confirming the potential of its restorative vascular ...
Acella Pharmaceuticals and Neuvosyn Laboratories have announced positive topline results from a phase 2 clinical trial of ...
Three new studies have launched in Manchester to evaluate the effectiveness of vaccines for severe acute respiratory ...
Tezspire (tezepelumab) has received a positive opinion from the CHMP for the treatment of chronic rhinosinusitis with nasal ...
BlueRock Therapeutics has dosed the first patient in its pivotal phase 3 trial of bemdaneprocel, an investigational cell ...
Johnson & Johnson has announced a positive opinion from the CHMP recommending expanded marketing authorisation for TREMFYA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback